JULIE ABELN: Open Payments
NPI 1932416187 · BELLEVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$522 in 28 payments from 9 companies in 2025. Trend: 2023 $666 · 2024 $516 · 2025 $522
Food & beverage: $522
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $105 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $102 |
| Sumitomo Pharma America, Inc. | 5 | $95 |
| Exeltis, USA Inc. | 3 | $56 |
| Sage Therapeutics, LLC | 2 | $47 |
| Astellas Pharma US Inc | 2 | $40 |
| Evofem Biosciences, Inc. | 2 | $38 |
| Hologic Sales and Service, LLC | 1 | $22 |
| Novo Nordisk Inc | 1 | $18 |
Products named: MYFEMBREE, LILETTA, SLYND, ZURZUVAE, UBRELVY, Veozah, Phexxi, APTIMA.
Industry payments across IL — which companies pay providers there.
